Single-dose miv-cel continues to demonstrate promising clinical benefit in progressive multiple sclerosis, achieving robust ...
SUN-627 demonstrated favorable safety, tolerability, and pharmacokinetics for oral, once-daily dosing in healthy ...
Neurologist Sonia Singh, M.D., specializes in caring for people with multiple sclerosis at MUSC Health, which has the state’s only comprehensive MS center. Since the actress Christina Applegate ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company’s Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic CD19-directed ...
A case report in BMC Pediatrics describes a 14-year-old girl whose severe functional constipation mimicked acute intracranial ...
A comprehensive review maps how MRI protocols and antibody testing are reshaping the diagnosis of childhood demyelinating ...
Favorable safety profile exhibited across three Phase 1 studies and Phase 2 cryptococcal meningitis study - Turletricin demonstrated clinically ...
Brezosiran and the Phase 1b results will be featured as part of Alnylam’s 10th “RNAi Roundtable” series on October 26, 2026, ...
Voyager Therapeutics, Inc. stays a Strong Buy as its dual Alzheimer’s programs near key 2026-2027 catalysts. Click for this ...
When actor Christina Applegate revealed that she had been misdiagnosed with multiple sclerosis, it triggered not only an ...
Neurologist Sonia Singh, M.D., explains what multiple sclerosis is and how it is diagnosed, noting the complexity highlighted by Christina Applegate’s case.
Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results